Table 1.
Characterization of participants.
| SZ Patients (N=32) | BD Patients (N=31) | Controls (N=30) | Group Comparison | ||
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | Statistic | p | |
| Age | 44.66 (12.44) | 43.74 (13.15) | 48.00 (6.54) | F(2,90)=1.23 | p=0.30 |
| Illness Duration | 23.91 (13.51) | 22.50 (12.61) | t(58)=0.42 | p=0.68 | |
| Education | 12.81 (1.94) | 13.94 (2.34) | 14.33 (1.83) | F(2,90)=4.64 | p=0.01 |
| Parental Education | 12.88 (2.56) | 13.83 (2.74) | 13.43 (3.01) | F(2,82)=0.86 | p=0.43 |
| Gender (M/F) | 23 / 9 | 13 / 18 | 15 / 15 | Χ2(2)=6.12 | p=0.05 |
| Handedness (R/L) | 27 / 5 | 27 / 4 | 26 / 4 | Χ2(2)=0.11 | p=0.95 |
| BD Type: I / II | 20 / 11 | ||||
|
| |||||
| BPRS (Total) | 40.47 (12.23) | 32.77 (9.09) | t(61)=2.83 | p=0.01 | |
| HAM-D (Total) | 7.38 (6.26) | 7.26 (4.61) | t(61)=0.08 | p=0.93 | |
| YMRS (Total) | 5.06 (3.93) | 4.06 (5.02) | t(61)=0.88 | p=0.38 | |
| Antipsychotic medication (Y/N) | 28 / 4 | 20 / 11 | Χ2(1)=4.59 | p=0.03 | |
| CPZ-equivalent dosage (mg/day) | 516.15 (407.08) | 257.60 (160.03) | t(33)=2.32 | p=0.03 | |
| Mood stabilizer frequency (Y/N) | 10 / 23 | 23 / 8 | Χ2(1)=12.33 | p=0.01 | |